Researcher
Dr. Hataichanok Chuljerm
Documents 1
Internal projects 1
External projects 1
School
School of Allied Health Sciences
School of Allied Health Sciences
Major
Medical Technology Program
Medical Technology Program
Email
hataichanok.ch@wu.ac.th
hataichanok.ch@wu.ac.th
Never entered data
| Quartile | Manuscript in Preparation | Journal Processing | Research Article | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Experiment | Data analysis | Review by mentor | Submission | Under review | Revision | Accepted Pending approval / Approved |
Published Pending approval / Approved |
|||
| Pending | Approved | Pending | Approved | |||||||
| Q1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Article | Participants | Journal | Fiscal | Selected 1 : 1 | Status | Approval | assessment | |
|---|---|---|---|---|---|---|---|---|
| 1 | 21693 | Anti-Malarial and Anti-Lipid Peroxidation Activities of Deferiprone-Resveratrol Hybrid in Plasmodium berghei-Infected Mice (2021-09-01) 10.3390/biology10090911 | Chuljerm, Hataichanok (F) Koonyosying, Pimpisid (C) maneekesorn, Supawadee (Co) Somsak, Voravuth (Co) Srichairatanakool, Somdet (Co) Ma, Yongmin (Co) | Biology (Q1), Volume 10, Issue 9, Pages number 911 | 2021 | เคลมผลงาน 1:1 ในปี 2021 | Published | Approved | Assessed in 2021 |
| Document title | Participation | Duration | Fiscal year | Funding | Progress | |
|---|---|---|---|---|---|---|
| 1 | WU64337 | The protective effect of deferiprone-resveratrol hybrid compound on the neurodegeneration. (WU-IRG-64-044) | Dr. Hataichanok Chuljerm 70 % | 15 Feb 2021 - 14 Feb 2022 14 May 2022 (Time out) | Extension 1st time | 2021 | 100,000 | Published Project is close 2024-03-19 14:49:09 |
| Document title | Participation | Duration | Source | Fiscal year | Funding | Progress | |
|---|---|---|---|---|---|---|---|
| 1 | RGNS64-207 | ผลของยาขับเหล็กลูกผสม deferiprone-resveratrol hybrid (DRH) ต่อการปกป้องตับจากการถูกทำลายในเซลล์เพาะเลี้ยงและหนูธาลัสซีเมียที่มีภาวะธาตุเหล็กเกิน COE / RC : Research Excellence Center for Innovation and Health Products | Dr. Hataichanok Chuljerm 100 % | 07 Mar 2022 - 06 Mar 2024 | Office of the Permonent Secretory | 2022 | 600,000 | In process |